EXCLUSIVE: This New Supplement Wants to Give Ozempic Effects a Thing of the Past.

Ozempic’s lunatic shakes up the extra team.

On Wednesday, SoWell, a supplement brand founded by double board certified obesity doctor Alexandra Sowa, is launching the GLP-1 Support System for $105. System includes Electrolytes, $35; Protein, $45, and Fiber, $35, are all tailored to the needs of GLP-1 users and their side effects. To begin with, it will be available directly to consumers and will begin select retailers in September, Sowa said.

“[The system] it was created because I needed products for my patients, and there was nothing on the market designed for the unique needs of GLP-1 users,” he said, adding that he started working on products in the last 18 months.

Over the past year, many supplement brands and retailers have jumped on the weight loss craze. When berberine, invented natural Ozempic, was fashionable, many supplement products launched their versions. The Vitamin Shoppe recently offered a wall of products that support GLP-1 users, containing proteins, electrolytes, fiber and probiotics aimed at addressing side effects such as nausea and muscle loss.

Although there is a lot of noise in this category, Sowa aims to break through the noise by using his experience of supplying GLP-1s over the last decade to create a product line.

“I’m still writing [prescriptions for] GLP-1 drugs have been part of my general medical practice for more than 10 years, and I quickly realized that there is much more I can do in clinical practice,” he said. “SoWell is driven by a desire to help more people and bring unique knowledge about metabolic health to the world.”

The brand’s electrolytes are low carb and low sugar, Sowa said. This product also includes ingredients like vitamin B6, which is said to help with nausea.

“One of the issues with using GLP-1 drugs is that your thirst and your hunger pangs are greatly reduced,” said Sowa, adding that the formulations are designed to be easier to swallow. buds of GLP-1 users.

“The taste buds change this drug and your brain in relation to the type of flavors it wants to change,” he said. what the GLP-1 user wants.”

Although discussions about Ozempic and weight-loss drugs continue, especially after Oprah shared her journey, Sowa says there has been no news yet. more about managing symptoms and supporting medication, which ends up keeping people from knowing.

He said: “Up to 70 percent of users stop the medication in a year, and one of the factors that contribute to stopping the medication is side effects.” “You will not see the full benefit of this medication if you stop prematurely and without a plan. Our goal with the company is to create a solution to help people feel better, reduce side effects and to be the companion of this medicine.”

With that in mind, Sowa sees great opportunity to continue launching products that support GLP-1 users. “Our goal is to create an ecosystem of products designed for GLP-1 users,” he said.

One in eight Americans has tried a drug like Ozempic, according to a KFF (Kaiser Family Foundation) health tracking study. Sowa only expects this number to grow as new research shows more benefits and the drugs are more readily available.

“Almost every month, there’s a new study coming out that gives these drugs additional indications to treat everything from sleep apnea to preventing heart disease, PCOS. [and] infertility,” he said. “These drugs aren’t going anywhere, and their progress is huge.”